期刊文献+

葡萄糖激酶基因杂合突变致新生儿糖尿病一例报告并文献复习 被引量:1

Neonatal diabetes mellitus with heterozygous mutations in the glucokinase gene:One case report and review of the literature
原文传递
导出
摘要 回顾分析一例由葡萄糖激酶(GCK )基因杂合突变所致新生儿糖尿病(NDM )的临床资料和分子遗传学特征。仅予饮食干预后随访末稍血糖:FBG 6.5~8.6 mmol/L、餐后血糖(PBG )7.1~11.3 mmol/L ,FIns 2.12~10.74 mIU/ml ,FC‐P 1.2~1.5 ng/ml ,HbA1 c 6.8%。调查患儿家系14名,发现4例糖尿病患者(患儿的姨母和母亲:GDM和糖尿病;外祖父和祖父:糖尿病),患儿及其母亲存在GCK基因c.1190G> T(p.Arg397Leu)杂合突变,其父亲和双胎妹妹未见基因突变。GCK 基因杂合突变引起NDM 还是M ODY2还需进一步结合临床和基因检查鉴别,对于NDM 患儿,尤其是有糖尿病家族史者,基因检测对病因诊断尤为重要。 [Summary] We retrospectively described the clinical and genetic characteristics in one case of neonatal diabetes mellitus (NDM ) with heterozygous mutations in glucokinase (GCK ) gene. During the follow‐up period with diabetes diet therapy ,the self‐monitoring fasting glucose swung from 6.5 to 8.6 mmol/L ,postprandial glucose 7.1~11.3 mmol/L ,fasting insulin (FIns)2.12~10.74 mIU/ml ,C‐peptide (FC‐P)1.2~ 1.5 ng/ml and HbA1 c maintained at 6.8% . Among 14 family members ,his mother and maternal aunt had gestational diabetes and diabetes. His maternal grandpa and grandpa had diabetes.There were heterozygous mutations in GCK gene(c.1190G〉 T ,p.Arg397Leu) in proband and his mother , but not in his father and his twin sister. Review of the literature indicated that GCK gene heterozygous mutations can cause PNDM and MODY2. Clinical characteristics and gene sequencing are very important in the diagnosis of PNDM and MODY2 ,especially in patients with family history of diabetes.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2016年第7期652-654,共3页 Chinese Journal of Diabetes
基金 广东省医学科学技术研究基金(A2015123)
关键词 葡萄糖激酶 基因突变 糖尿病 新生儿 Glucokinase (GCK) Gene mutation Diabetes mellitus Neonatal
  • 相关文献

参考文献12

  • 1Pagon RA, Adam MP, Ardinger HH, et al. Gene reviews. Seat- tle (WA) .- University of Washington, 1993-2015.
  • 2Iafuseo D, Massa O, Pasquino B, et al. Minimal incidence of neo- natal/infancy onset diabetes in Italy is 1 : 90, 000 live births. Acta Diabetol, 2012,49 : 405-408.
  • 3Naylor RN, Greeley SA, Bell GI, et al. Genetics and pathophys- iology of neonatal diabetes mellitus. J Diabetes Investig, 2011, 2:158-169.
  • 4Osbak KK,Colclough K, Saint-Martin C, et al. Update on mu- tations in glucokinase (GCK),which cause maturity-onset dia- betes of the young, permanent neonatal diabetes, and hyperin- sulinemic hypoglycemia. Hum Mutat, 2009,30:1512-1526.
  • 5Kerti Pulst, Triin Arbo, Tiina Kahre, et al. MODY2 caused by a novel mutation of GCK gene. J Pediatr Endocrinol Metab, 2012,25:801-803.
  • 6Maciej B, Malgorzata M, Wojciech F, et al. Phenotype variabili- ty and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene. Acta Diabetol, 2011,48:203- 208.
  • 7Barbetti F,Cobo-Vuilleumier N, Dionisi-Vici C, et al. Opposite clinical phenotypes of glucokinase disease:description oi a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. Mol Endoerinol, 2009, 23: 1983-1989.
  • 8Wajda-Cuszlag M, Witkowski D, Piontck E, et al. Glucokinase gene mutation as a causative factor of permanent neonatal dia- betes mellitus. Pediatr Endoerinol Diabetes Metab, 2012, 18: 45-47.
  • 9Maltoni G, Zucchini S, Mattini AL, et al. Clinical heterogeneity in the same generation of siblings with GCK/MODY 2. Diabetes Res Clin Ptact, 2015,107 : el-e3.
  • 10刁呈明,萨仁图雅,肖新华,孙晓方,茅李莉,张茜,李文慧,于淼,袁涛,黎明,向红丁,王姮.两个MODY2中国家系葡萄糖激酶基因杂合突变的研究[J].中国糖尿病杂志,2010,18(6):405-408. 被引量:5

二级参考文献10

  • 1Gat-Yablonski G,Shalitin S,Phillip M.Maturity onset diabetes of the young--review.Pediatr Endocrinol Rev,2007,5:470.
  • 2Yamagata K,Furuta H,Oda N,et al.Mutations in the hepatocyte nuclear factor-4-alpha gene in maturity-onset diabetes of the young (MODY1).Nature,1996,384:458-460.
  • 3Njolstad PR,Sovik O,Cuesta-Munoz A,et al.Neonatal diabetes mellitus due to complete glucokinase deficiency.N Engl J Med,2001,344:1588-1592.
  • 4Anna LG.Glucokinase(GCK) mutations in hyper-and hypoglycemia:maturity-onset diabetes of the Young,permanent neonatal diabetes,and hyperinsulinemia of infancy.Human Mutation,2003,22:353-362.
  • 5Stride A,Vaxillaire M,Tuomi T,et al.The genetic abnormality in the β cell determines the response to an oral glucose load.Diabetologia,2002,45:427-435.
  • 6Nyunt O,Wu JY,McGown IN,et al.Investigating maturity onset diabetes of the young.Clin Biochem Rev,2009,30:67-70.
  • 7Garcia-Herrero CM,Galan M,Vincent O,et al.Functional analysis of human glucokinase gene mutations causing MODY2:exploring the regulatory mechanisms of glucokinase activity.Diabetologia,2007,50:325-333.
  • 8Gloyn AL,Tribble ND,Bunt M,et al.Glucokinase(GCK) and other susceptibility genes for β-cell dysfunction:the candidate approach.Biochem Soc Trans,2008,36:306-311.
  • 9Murphy R,Ellard S,Hattersley AT.Clinical implication of a molecular genetic classification of monogenic beta-cell diabetes.Nat Clin Pract Endocrinol Metab,2008,4:200-213.
  • 10Hattersley AT,Turner RC,Permutt MA,et al.Linkage of type 2 diabetes to the glucokinase gene.Lancet,1992,339:1307-1310.

共引文献4

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部